Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Moxaverine effects on ocular blood flow
NCT00569621Phase 2Completed
- Sponsor
- Medical University of Vienna
- Start
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of moxaverine in ocular ischemic syndrome (OIS), sponsored by Medical University of Vienna. Started Mar 2007; status: completed.
02
Drugs
moxaverine
03
Conditions
ocular ischemic syndrome (OIS)
Beyond the preview
Go deeper on NCT00569621.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00569621.